Parexel Consulting has expanded its risk management and strategic compliance expertise with the appointment of Raymond T. Oji to the position of senior consultant. Formerly a microbiologist and consumer safety officer in the FDA San Francisco District, Mr. Oji has 40 years of experience in performing pharmaceutical inspections and drug and device analyses. He joins a global network of consultants dedicated to addressing risk management challenges.
"Parexel Consulting integrates scientific and regulatory compliance expertise with business performance expertise, represented by consultants such as Ray. Clients turn to our experts to help them respond rapidly and effectively to regulatory actions and avoid potential problems that could negatively impact business performance. Our goal is to help clients proactively assess and prevent risks to ensure successful product development and business outcomes," said Kurt Brykman, president of Parexel Consulting and Medical Communications.
Mr. Oji's background as a consumer safety officer and microbiologist with the FDA included conducting GMP and pre-approval inspections and audits worldwide of pharmaceutical manufacturing facilities in the areas of aseptic filling and processing, terminal sterilization, APIs and OTC drug production, as well as auditing pharmaceutical microbiology and chemistry laboratory operations. Mr. Oji also developed and performed analytical procedures and managed clean room operations, serving as a principal analyst for testing sterile drugs and devices. He has performed the full range of procedures for drug and device analyses including sterility, endotoxin, bioburden, microbial limits, water and environmental monitoring.